Tobias Täger1, Miriam Schell1, Rita Cebola1, Hanna Fröhlich1, Andreas Dösch1, Jennifer Franke1, Hugo A Katus1, Frank H Wians2, Lutz Frankenstein3. 1. Department of Cardiology, Angiology, and Pulmonology, University of Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany. 2. Department of Pathology, Baylor University Medical Center, Dallas, TX, USA. 3. Department of Cardiology, Angiology, and Pulmonology, University of Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany. Lutz.Frankenstein@med.uni-heidelberg.de.
Abstract
BACKGROUND: Despite the widespread application of measurements of respiratory muscle force (PImax) in clinical trials there is no data on biological variation, reference change value (RCV), or the minimal important difference (MID) for PImax irrespective of the target cohort. We addressed this issue for patients with chronic stable heart failure. METHODS AND RESULTS: From the outpatients' clinic of the University of Heidelberg we retrospectively selected three groups of patients with stable systolic chronic heart failure (CHF). Each group had two measurements of PImax: 90 days apart in Group A (n = 25), 180 days apart in Group B (n = 93), and 365 days apart in Group C (n = 184). Stability was defined as (a) no change in NYHA class between visits and (b) absence of cardiac decompensation 3 months prior, during, and 3 months after measurements. For each group, we determined within-subject (CVI), between-subject (CVG), and total (CVT) coefficient of variation (CV), the index of individuality (II), RCV, reliability coefficient, and MID of PImax. CVT was 8.7, 7.5, and 6.9 % for groups A, B, and C, respectively. The II and RCV were 0.21, 0.20, 0.16 and 13.6, 11.6, 10.8 %, respectively. The reliability coefficient and MID were 0.83, 0.87, 0.88 and 1.44, 1.06, 1.12 kPa, respectively. Results were similar between age, gender, and aetiology subgroups. CONCLUSION: In patients with stable CHF, measurements of PImax are highly stable for intervals up to 1 year. The low values for II suggest that evaluation of change in PImax should be performed on an individual (per patient) basis. Individually significant change can be assumed beyond 14 % (RCV) or 1.12 kPa (MID).
BACKGROUND: Despite the widespread application of measurements of respiratory muscle force (PImax) in clinical trials there is no data on biological variation, reference change value (RCV), or the minimal important difference (MID) for PImax irrespective of the target cohort. We addressed this issue for patients with chronic stable heart failure. METHODS AND RESULTS: From the outpatients' clinic of the University of Heidelberg we retrospectively selected three groups of patients with stable systolic chronic heart failure (CHF). Each group had two measurements of PImax: 90 days apart in Group A (n = 25), 180 days apart in Group B (n = 93), and 365 days apart in Group C (n = 184). Stability was defined as (a) no change in NYHA class between visits and (b) absence of cardiac decompensation 3 months prior, during, and 3 months after measurements. For each group, we determined within-subject (CVI), between-subject (CVG), and total (CVT) coefficient of variation (CV), the index of individuality (II), RCV, reliability coefficient, and MID of PImax. CVT was 8.7, 7.5, and 6.9 % for groups A, B, and C, respectively. The II and RCV were 0.21, 0.20, 0.16 and 13.6, 11.6, 10.8 %, respectively. The reliability coefficient and MID were 0.83, 0.87, 0.88 and 1.44, 1.06, 1.12 kPa, respectively. Results were similar between age, gender, and aetiology subgroups. CONCLUSION: In patients with stable CHF, measurements of PImax are highly stable for intervals up to 1 year. The low values for II suggest that evaluation of change in PImax should be performed on an individual (per patient) basis. Individually significant change can be assumed beyond 14 % (RCV) or 1.12 kPa (MID).
Entities:
Keywords:
Biological variation; Chronic heart failure; Inspiratory muscle strength; Minimal important difference; PImax; Reference change value
Authors: Arthur Filusch; Ralf Ewert; Maike Altesellmeier; Christian Zugck; Roland Hetzer; Mathias M Borst; Hugo A Katus; F Joachim Meyer Journal: Int J Cardiol Date: 2010-05-04 Impact factor: 4.164
Authors: Rodrigo B Jaenisch; Vítor S Hentschke; Edson Quagliotto; Paulo R Cavinato; Letiane A Schmeing; Léder L Xavier; Pedro Dal Lago Journal: J Appl Physiol (1985) Date: 2011-09-08
Authors: Ioannis D Laoutaris; Athanasios Dritsas; Margaret D Brown; Athanassios Manginas; Manolis S Kallistratos; Antigoni Chaidaroglou; Dimitrios Degiannis; Peter A Alivizatos; Dennis V Cokkinos Journal: J Cardiopulm Rehabil Prev Date: 2008 Mar-Apr Impact factor: 2.081